| Serum irisin and apelin levels and markers of atherosclerosis in patients with subclinical hypothyroidism HY Yasar, M Demirpence, A Colak, L Yurdakul, M Zeytinli, H Turkon, ... Archives of endocrinology and metabolism 63, 16-21, 2019 | 26 | 2019 |
| Level of COVID-19 fear in cancer patients AP Erdoğan, F Ekinci, Ö Acar, G Göksel Middle East Current Psychiatry 29 (1), 9, 2022 | 18 | 2022 |
| HALP score as a new prognostic index in metastatic renal cell cancer F Ekinci, OY Balcik, E Oktay, AP Erdogan J. Coll. Physicians Surg. Pak 32, 313-318, 2022 | 15 | 2022 |
| A Rare case report of skin metastasis in gastric cancer M Şahin, F Ekinci, C Çelik, P Temiz, AP Erdoğan, G Göksel Journal of Gastrointestinal Cancer 52, 1156-1158, 2021 | 7 | 2021 |
| Amiodarone-induced hyponatremia in an elderly patient O Oner, UE Soyaltin, H Akar, F Ekinci, A Komaç, F Elyigit European Geriatric Medicine 6 (5), 476-477, 2015 | 6 | 2015 |
| The inflammatory prognostic index as a potential predictor of prognosis in metastatic gastric cancer A Ozveren, AP Erdogan, F Ekinci Scientific Reports 13 (1), 7755, 2023 | 5 | 2023 |
| Factors affecting the serologic response to SARS-CoV-2 vaccination in patients with solid tumors: a prospective study AP Erdoğan, F Ekinci, S Akçalı, G Göksel Journal of Infection and Chemotherapy 28 (9), 1310-1316, 2022 | 5 | 2022 |
| Could the inflammatory prognostic index predict the efficacy of regorafenib in patients with metastatic colorectal cancer? AP Erdoğan, F Ekinci, A Karabaş, OY Balçık, S Barutça, A Dirican Journal of Gastrointestinal Cancer, 1-7, 2022 | 4 | 2022 |
| A rare case of Rhabdomyolysis probably due to donepezil F Ekinci, UE Soyaltin, MC Ugur, A Develi, H Akar J Clin Case Rep 4 (465), 2, 2014 | 4 | 2014 |
| The real‐world outcomes of Lutetium‐177 PSMA‐617 radioligand therapy in metastatic castration‐resistant prostate cancer: Turkish Oncology Group multicenter study E Almuradova, M Seyyar, H Arak, F Tamer, U Kefeli, S Koca, E Sen, ... International Journal of Cancer 154 (4), 692-700, 2024 | 2 | 2024 |
| Systemic immune inflammation index as a key marker of survival and immune-related adverse events in immune checkpoint inhibitor therapy F Ekinci, OY Balcik, B Demir, P Gursoy, A Ozveren, AP Erdogan J Coll Phys Surg Pak 32 (8), 996-1003, 2022 | 2 | 2022 |
| Palliative Biliary Drainage Has No Effect on Survival in Pancreatic Cancer: Medical Oncology Perspective AP Erdoğan, F Ekinci, S Yıldırım, A Özveren, G Göksel Journal of Gastrointestinal Cancer, 1-5, 2022 | 2 | 2022 |
| Can Albumin Bilirubin Ratio and Inflammatory Prognostic Index Be A New Marker Determining Survival in Metastatic Pancreatic Cancer? F Ekinci, D Sarı, C Çelik, A Dirican, AP Erdoğan, G Gökse The Gulf Journal of Oncology 1 (36), 45-52, 2021 | 2 | 2021 |
| The effect of neutrophil lymphocyte ratio on prognosis in patients with metastatic renal cell carcinoma F EKİNCİ, AP ERDOĞAN, A DİRİCAN, G GÖKSEL Abant Tıp Dergisi 10 (1), 134-139, 2021 | 2 | 2021 |
| Inflammatory prognostic index score as a new parameter predicting overall survival in renal cell carcinoma A Dirican, F Ekinci, AP ERDOĞAN, G GÖKSEL Journal of Surgery and Medicine 5 (2), 163-167, 2021 | 2 | 2021 |
| Options in First Line Management of Metastatic Pancreatic Cancer and the Determinative Role of ECOG Performance Status F Ekinci, AP Erdogan, S Yildirim, A Ozveren Eurasian Journal of Medical Investigation 5 (4), 500-507, 2021 | 2 | 2021 |
| Polycythemia Vera Associated with IgA Nephropathy: A Case Report T Yildirim, U Soyaltin, A Komac, F Ekinci, H Akar TURKISH NEPHROLOGY DIALYSIS AND TRANSPLANTATION JOURNAL 25 (2), 2016 | 2 | 2016 |
| Assessment of adrenal incidentaloma patients F Ekinci, UE Soyaltın, HY Yaşar, H Akar, TD Yıldırım, MC Uğur, E Ersoy ANATOLIAN JOURNAL OF GENERAL MEDICAL RESEARCH 26 (1), 10-14, 2016 | 2 | 2016 |
| Efficacy of Neoadjuvant Chemotherapy in Lobular and Rare Subtypes of Breast Cancer E Seber, Y Iriagac, E Cavdar, K Karaboyun, O Avci, A Yolcu, S Gurdal, ... Journal of the College of Physicians and Surgeons--Pakistan: JCPSP 34 (1), 2024 | 1 | 2024 |
| HALP Score as a New Prognostic Factor for Patients with Metastatic Bladder Cancer O Acar, M Ayhan, B Demir, F Ekinci, A Aytac, AP Erdogan Age (Median (IQR) 69, 63-75, 2023 | 1 | 2023 |
